BIOMAT Database Logo BIOMAT Database Logo

Efficacy of influenza vaccination in adult liver transplant recipients. 2000

N M Soesman, and G F Rimmelzwaan, and N J Nieuwkoop, and W E Beyer, and H W Tilanus, and M H Kemmeren, and H J Metselaar, and R A de Man, and A D Osterhaus
Department of Virology, National Influenza Center, Erasmus Medical Center, Rotterdam, the Netherlands.

To assess the efficacy of influenza vaccination in immunocompromised adult liver transplant (LTx) recipients, the serum antibody responses of 61 of these patients and 35 liver cirrhosis patients with those of 45 of their healthy spouses were compared, after one and two vaccinations with a commercial trivalent subunit influenza vaccine. In addition, virus-specific proliferative T-cell responses were measured in LTx recipients and their healthy spouses. In all three study groups, significant rises in geometric mean antibody titers were observed for all three antigens after one vaccination. These titers did not continue to increase significantly after the second vaccination in patients with cirrhosis and control subjects but did rise for LTx recipients. The overall antibody response to all three influenza virus strains proved to be significantly lower in the LTx recipients than in the group of healthy subjects after both one and two vaccinations. More than 68% of the LTx recipients developed hemagglutination-inhibiting serum antibody titers >/=40 against all three vaccine strains after the first vaccination and more than 80% after the second vaccination. These findings correlated with the T-cell responses determined for the group of LTx recipients and healthy control individuals. Testing of the respective serum samples against influenza virus A/Sydney/5/97, which circulated in the 1997-1998 influenza season and showed a considerable mismatch with the vaccine strain A/Nanchang/933/95, indicated that such a mismatch may have significant consequences for vaccine efficacy, especially for LTx recipients. Collectively the data show that LTx recipients can be vaccinated effectively against influenza despite immunosuppressive therapy. A two-dose vaccination regimen improved vaccination efficacy in LTx recipients. Whether transplant patients generally benefit from a two-dose vaccination regimen should be evaluated further.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D009981 Influenza B virus Species of the genus BETAINFLUENZAVIRUS that cause HUMAN INFLUENZA and other diseases primarily in humans. Antigenic variation is less extensive than in type A viruses (INFLUENZA A VIRUS) and consequently there is no basis for distinct subtypes or variants. Epidemics are less likely than with INFLUENZA A VIRUS and there have been no pandemics. Previously only found in humans, Influenza B virus has been isolated from seals which may constitute the animal reservoir from which humans are exposed. Betainfluenzavirus influenzae,FLUBV,Human Influenza B Virus,Influenza Viruses Type B,Influenza virus type B,Orthomyxoviruses Type B,Influenza B viruses
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D005260 Female Females

Related Publications

N M Soesman, and G F Rimmelzwaan, and N J Nieuwkoop, and W E Beyer, and H W Tilanus, and M H Kemmeren, and H J Metselaar, and R A de Man, and A D Osterhaus
Influenza vaccination in liver transplant recipients.
March 1999, Transplantation,
N M Soesman, and G F Rimmelzwaan, and N J Nieuwkoop, and W E Beyer, and H W Tilanus, and M H Kemmeren, and H J Metselaar, and R A de Man, and A D Osterhaus
Safety and efficacy of influenza vaccination in renal transplant recipients.
July 2008, Nature clinical practice. Nephrology,
N M Soesman, and G F Rimmelzwaan, and N J Nieuwkoop, and W E Beyer, and H W Tilanus, and M H Kemmeren, and H J Metselaar, and R A de Man, and A D Osterhaus
Influenza vaccination in heart transplant recipients.
March 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
N M Soesman, and G F Rimmelzwaan, and N J Nieuwkoop, and W E Beyer, and H W Tilanus, and M H Kemmeren, and H J Metselaar, and R A de Man, and A D Osterhaus
Influenza vaccination in renal transplant recipients.
February 1978, JAMA,
N M Soesman, and G F Rimmelzwaan, and N J Nieuwkoop, and W E Beyer, and H W Tilanus, and M H Kemmeren, and H J Metselaar, and R A de Man, and A D Osterhaus
Influenza vaccination in patients with cirrhosis and in liver transplant recipients.
May 2009, Vaccine,
N M Soesman, and G F Rimmelzwaan, and N J Nieuwkoop, and W E Beyer, and H W Tilanus, and M H Kemmeren, and H J Metselaar, and R A de Man, and A D Osterhaus
Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients.
March 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
N M Soesman, and G F Rimmelzwaan, and N J Nieuwkoop, and W E Beyer, and H W Tilanus, and M H Kemmeren, and H J Metselaar, and R A de Man, and A D Osterhaus
Immune response to influenza vaccine in adult liver transplant recipients.
April 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
N M Soesman, and G F Rimmelzwaan, and N J Nieuwkoop, and W E Beyer, and H W Tilanus, and M H Kemmeren, and H J Metselaar, and R A de Man, and A D Osterhaus
Influenza vaccination among heart transplant recipients.
January 2001, Transplantation proceedings,
N M Soesman, and G F Rimmelzwaan, and N J Nieuwkoop, and W E Beyer, and H W Tilanus, and M H Kemmeren, and H J Metselaar, and R A de Man, and A D Osterhaus
Influenza vaccination in solid-organ transplant recipients.
December 2012, Current opinion in organ transplantation,
N M Soesman, and G F Rimmelzwaan, and N J Nieuwkoop, and W E Beyer, and H W Tilanus, and M H Kemmeren, and H J Metselaar, and R A de Man, and A D Osterhaus
Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation.
November 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Copied contents to your clipboard!